These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 24662018

  • 1. Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection.
    Cargnelutti DE, Salomón MC, Celedon V, García Bustos MF, Morea G, Cuello-Carrión FD, Scodeller EA.
    J Microbiol Immunol Infect; 2016 Feb; 49(1):24-32. PubMed ID: 24662018
    [Abstract] [Full Text] [Related]

  • 2. Total Leishmania antigens with Poly(I:C) induce Th1 protective response.
    Sanchez MV, Eliçabe RJ, Di Genaro MS, Germanó MJ, Gea S, García Bustos MF, Salomón MC, Scodeller EA, Cargnelutti DE.
    Parasite Immunol; 2017 Nov; 39(11):. PubMed ID: 28901553
    [Abstract] [Full Text] [Related]

  • 3. Comparing Montanide ISA 720 and 50-V2 adjuvants formulated with LmSTI1 protein of Leishmania major indicated the potential cytokine patterns for induction of protective immune responses in BALB/c mice.
    Shokri M, Roohvand F, Alimohammadian MH, Ebrahimirad M, Ajdary S.
    Mol Immunol; 2016 Aug; 76():108-15. PubMed ID: 27428863
    [Abstract] [Full Text] [Related]

  • 4. Identification of Immunodominant Antigens From a First-Generation Vaccine Against Cutaneous Leishmaniasis.
    Germanó MJ, Mackern-Oberti JP, Vitório JG, Duarte MC, Pimenta DC, Sanchez MV, Bruna FA, Lozano ES, Fernandes AP, Cargnelutti DE.
    Front Immunol; 2022 Aug; 13():825007. PubMed ID: 35634280
    [Abstract] [Full Text] [Related]

  • 5. Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.
    Coelho EA, Tavares CA, Carvalho FA, Chaves KF, Teixeira KN, Rodrigues RC, Charest H, Matlashewski G, Gazzinelli RT, Fernandes AP.
    Infect Immun; 2003 Jul; 71(7):3988-94. PubMed ID: 12819086
    [Abstract] [Full Text] [Related]

  • 6. Antigenic extracts of Leishmania braziliensis and Leishmania amazonensis associated with saponin partially protects BALB/c mice against Leishmania chagasi infection by suppressing IL-10 and IL-4 production.
    Grenfell RF, Marques-da-Silva EA, Souza-Testasicca MC, Coelho EA, Fernandes AP, Afonso LC, Rezende SA.
    Mem Inst Oswaldo Cruz; 2010 Sep; 105(6):818-22. PubMed ID: 20944999
    [Abstract] [Full Text] [Related]

  • 7. Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.
    Ferreira JH, Gentil LG, Dias SS, Fedeli CE, Katz S, Barbiéri CL.
    Vaccine; 2008 Jan 30; 26(5):677-85. PubMed ID: 18160187
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis.
    Abdian N, Gholami E, Zahedifard F, Safaee N, Rafati S.
    Exp Parasitol; 2011 Mar 30; 127(3):627-36. PubMed ID: 21187087
    [Abstract] [Full Text] [Related]

  • 9. Intranasal vaccination with killed Leishmania amazonensis promastigotes antigen (LaAg) associated with CAF01 adjuvant induces partial protection in BALB/c mice challenged with Leishmania (infantum) chagasi.
    Leal JM, Mosquini M, Covre LP, Stagmiller NP, Rodrigues RR, Christensen D, de Matos Guedes HL, Rossi-Bergmann B, Gomes DC.
    Parasitology; 2015 Nov 30; 142(13):1640-6. PubMed ID: 26394776
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Leishmanization Using Iranian Lizard Leishmania Mixed With CpG-ODN as a Candidate Vaccine Against Experimental Murine Leishmaniasis.
    Keshavarzian N, Noroozbeygi M, Haji Molla Hoseini M, Yeganeh F.
    Front Immunol; 2020 Nov 30; 11():1725. PubMed ID: 33193290
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.
    Khoshgoo N, Zahedifard F, Azizi H, Taslimi Y, Alonso MJ, Rafati S.
    Vaccine; 2008 Oct 29; 26(46):5822-9. PubMed ID: 18804512
    [Abstract] [Full Text] [Related]

  • 18. A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection.
    Duarte MC, Lage DP, Martins VT, Costa LE, Carvalho AMRS, Ludolf F, Santos TTO, Vale DL, Roatt BM, Menezes-Souza D, Fernandes AP, Tavares CAP, Coelho EAF.
    Immunobiology; 2017 Feb 29; 222(2):251-260. PubMed ID: 27693018
    [Abstract] [Full Text] [Related]

  • 19. Immune induction by adjuvanted Leishmania donovani vaccines against the visceral leishmaniasis in BALB/c mice.
    Goyal DK, Keshav P, Kaur S.
    Immunobiology; 2021 Mar 29; 226(2):152057. PubMed ID: 33545508
    [Abstract] [Full Text] [Related]

  • 20. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins.
    Tafaghodi M, Eskandari M, Kharazizadeh M, Khamesipour A, Jaafari MR.
    Trop Biomed; 2010 Dec 29; 27(3):639-50. PubMed ID: 21399606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.